The most contrasting metastasis subtypes, MetA and MetB, can be identified using two immunohistochemical markers: Ki67 for tumor cell proliferation and PSA for luminal cell differentiation and androgen receptor (AR) activity [7, 8]. The gene discussed is AR; the disease is neoplasm.